Predictors of survival outcomes in patients with <i>MECOM EVI1</i> rearrangement aberrations in AML or MDS.Yael Kusne, Cecilia Ysabel Arana Yi, Talha Badar et al.|Journal of Clinical Oncology|2023Cited by 3
POSTER: AML-665 Predictors of Outcomes in Patients With MECOM EVI1 Rearranged AML or MDSYael Kusne, Cecilia Arana Yi, Alyssa McGary et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
AML-665 Predictors of Outcomes in Patients With MECOM EVI1 Rearranged AML or MDSYael Kusne, Cecilia Arana Yi, Patricia T. Greipp et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0